Today: 10 June 2026
GE Vernova stock flat after-hours as year-end trading thins; what investors watch next for GEV
30 December 2025
2 mins read

GE Vernova stock flat after-hours as year-end trading thins; what investors watch next for GEV

NEW YORK, December 29, 2025, 6:16 PM ET — After-hours

  • GE Vernova shares ended essentially flat at $663.46 in regular trading; after-hours action was muted.
  • Wall Street slipped in light year-end volume as tech stocks pulled back.
  • Focus is shifting to early-2026 results and execution against GE Vernova’s raised 2026 targets.

GE Vernova Inc shares were little changed in after-hours trading on Monday after finishing the regular session essentially flat, even as U.S. stocks ended lower to start the final week of 2025.

The pause matters because GE Vernova has become one of the market’s most closely watched “power buildout” names, and year-end sessions often amplify positioning as fund managers lock in gains or rebalance.

Investors have bid up power and grid suppliers on expectations that electricity demand from data centers will keep climbing, leaving the stock sensitive to any new signal on orders, margins and cash generation.

GE Vernova ended the regular session at $663.46. The stock traded between $651.77 and $670.99, with about 2.1 million shares changing hands, according to market data.

The broader tape was softer. The S&P 500 fell 0.35% and the Nasdaq dropped 0.50% as heavyweight technology names retreated, Reuters reported, in what it described as light holiday trading.

The company’s most recent catalyst came earlier this month. At a Dec. 9 investor update, GE Vernova forecast 2026 revenue of $41 billion to $42 billion and free cash flow of $4.5 billion to $5.0 billion, up from its 2025 targets; free cash flow is cash left after capital spending. It also projected 16% to 18% organic growth in its power segment and 20% in electrification, with organic growth excluding currency swings and acquisitions, and it lifted its share repurchase authorization to $10 billion while doubling its quarterly dividend to 50 cents a share.

GE Vernova’s improved outlook followed similar momentum across the gas turbine supply chain. Rivals Siemens Energy and Mitsubishi Heavy Industries have also raised targets, Reuters reported, underscoring the competitive rush to meet demand for large power equipment.

Even after Monday’s flat close, the stock is up about 102% year-to-date and sits about 9% below its 52-week high of $731, giving the company a market value of roughly $180 billion, according to market data compiled by Finviz.

Supply-chain risks remain on watch. GE Vernova Chief Executive Scott Strazik said the company is working with the U.S. government to build stockpiles of yttrium, a rare-earth element used in high-temperature coatings and alloys in gas turbines. “We are very focused on it every day,” Strazik said. Reuters

For traders, Monday’s intraday swing — a dip into the low $650s followed by a rebound — highlighted how quickly sentiment can shift around year-end, particularly in stocks that have run hard.

The next clear catalyst is the company’s fourth-quarter results. GE Vernova has not confirmed the reporting date, but MarketBeat lists an estimated earnings date of Jan. 28, 2026 based on prior reporting patterns.

Before that, investors will be looking for updates on orders, margins and cash returns as the company moves from guidance to delivery. GE Vernova has said its increased dividend is payable on Feb. 2, 2026 to shareholders of record on Jan. 5, a near-term marker for income-focused holders.

Stock Market Today

  • Can Palantir Technologies (PLTR) Stock Justify Its High Valuation?
    June 10, 2026, 11:05 AM EDT. Palantir Technologies (PLTR) trades at a steep 143.2x trailing earnings, reflecting market expectations for rapid growth and strong margins. The company׳s AI platform fuels surging U.S. government and commercial demand, pushing last twelve months revenue growth to 67.7%. However, sustaining a 34.5% compound annual growth rate over seven years is challenging amid potential defense budget delays and cyclical peak profit margins. Palantir must juggle expanding commercial opportunities with its critical defense commitments. Analysts caution that current high multiples leave little room for error, making PLTR a risky standalone stock. Investors might consider diversified strategies to mitigate volatility in high-valuation tech stocks like Palantir.

Latest articles

Chewy Drops After Q1 Beat With Outlook Warning

Chewy Drops After Q1 Beat With Outlook Warning

10 June 2026
Chewy slashed its 2026 net sales outlook to $13.40–$13.55 billion, below prior guidance and analyst estimates, sending shares down 50 cents to $19.90 as investors reacted to weaker-than-expected second-quarter forecasts despite a 7.7% first-quarter sales jump and improved profitability.
Nu Holdings Stock Moves Higher, Investors Weigh $1 Billion Buyback Impact

Nu Holdings Stock Moves Higher, Investors Weigh $1 Billion Buyback Impact

10 June 2026
Nu Holdings stock rebounded 1.3% to $12.04 early Wednesday after a $1 billion buyback was authorized, but shares remain down 30.5% over six months as investors weigh the buyback’s support against rising credit costs, a CFO transition that triggered analyst downgrades, and a jump in non-performing loans to 5.0% last quarter.
Keel Infrastructure Inches Up After $458M Debt Deal Amid AI Pivot

Keel Infrastructure Inches Up After $458M Debt Deal Amid AI Pivot

10 June 2026
Keel Infrastructure jumped 0.83% to $5.47 after closing a $458 million convertible-note sale, up from an initial $350 million plan, with proceeds aimed at AI data-center growth and capped calls to limit dilution up to $11.86 per share, as investors weigh new capital against added debt and future share issuance.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Next Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Go toTop